Local reaction characteristics: Confined to the injection site and immediately surrounding area Symptoms include redness, swelling, itching, pain, and warmth at the injection site only No systemic symptoms (no fever, no hives elsewhere, no breathing difficulty) Resolves within 3 to 7 days Does not typically worsen after the first 24 to 48 hours Systemic allergic reaction characteristics: Symptoms extend beyond the injection site Hives, rash, or flushing on areas distant from the injection site Respiratory symptoms (coughing, wheezing, throat tightness) Cardiovascular symptoms (rapid pulse, low blood pressure, dizziness) Gastrointestinal symptoms (nausea, vomiting, cramping) beyond typical GI side effects Local reactions almost never require discontinuation of tirzepatide
Direct-pay supervision is not a universal answer
How to Reduce Regain Risk When discussing stop GLP-1 medication weight regain, we emphasize that regain is not inevitable, but some degree of fluctuation is common
Whilst bad smelling burps are not specifically quantified as a distinct adverse effect in the Ozempic SmPC or clinical trial data, they may fall within the broader category of gastrointestinal disturbances experienced by patients
Packer noted that gastrointestinal reports, such as diarrhea, nausea, or constipation, led 4% discontinuation in the tirzepatide arm